HyperBranch Medical Technology, Inc. announced today that it has received a CE Mark for Adherus(TM) Spinal Sealant.
Momentive Performance Materials announced today that it has received the 2009 Frost & Sullivan Product Innovation of the Year Award for StatSil antimicrobial elastomer platform technology in the North American antimicrobial materials market.
DSM, which created and manufactures Dyneema Purity®, the world’s strongest Medical grade fiber, today announced agreements with Biomedical Structures, Cortland Company and Secant Medical.
These companies’ e...
BioNeutral Group, Inc., a specialty chemical technology-based life science company, reports that yesterday it received final test results from ATS Labs indicating that its Ygiene™ Hospital Grade Antimicrobial has passed the stringent Sporicidal GLP test requirements for hospital and medical environment sporicide efficacy claims mandated by the US EPA.
PolyOne Corporation (NYSE: POL) and Dow Corning confirmed today that PolyOne will distribute Dow Corning silicone products to healthcare device manufacturers and fabricators in the United States, Canada and Mexico. ...
Dow Corning will feature its expanded offering of liquid silicone rubber including Dow Corning® QP1 Liquid Silicone Rubber products, in Booth 1231 at MD&M East, June 8-10, at the Jacob K. Javitz Convention Center in New York City.
DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the Company will both exhibit and present at the upcoming Medical Design and Manufacturing East Conference & Exposition
Glycosan BioSystems announced today that the Company has begun the process for gaining regulatory approval within the European Union for the use of HyStem-Rx as a resorbable scaffold for implanting autologous adipos...
DuPont is accelerating its investments, driving innovation and commercializing market-leading products all to capitalize on significant market opportunities in the alternative energy sector, DuPont Executive Vice President and Chief Innovation Officer Thomas M. Connelly told investors at the Credit Suisse Future of Energy Conference.
RepRegen™, the ‘smart biomaterials’ company previously known as BioCeramic Therapeutics, announced today that three-month data from an in vivo study of its StronBone™ bioactive glass with Strontium demonstrated that it can generate bone quality in and around defects that appears by analytical tests to be significantly superior to a standard bone void filler in the control defect.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.